Back to top
more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$21.08 USD

21.08
1,055,547

-0.85 (-3.88%)

Updated Sep 5, 2024 04:00 PM ET

After-Market: $21.10 +0.02 (0.09%) 5:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Haemonetics (HAE) Hospital Arm Thrives, Gross Margin Rises

by Zacks Equity Research

Strong procedure recovery in the hospital business, the resilience of blood donors in blood centers and rollouts of Persona technology and NexSys aid Haemonetics (HAE).

Here's Why You Should Add Glaukos (GKOS) to Your Portfolio

by Zacks Equity Research

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Here's Why You Should Retain Walgreens Boots (WBA) For Now

by Zacks Equity Research

Investors are optimistic about Walgreens Boots (WBA), given its better-than-expected earnings and strategic alliances.

Cardinal Health's (CAH) New Buyout to Boost Medication Adherence

by Zacks Equity Research

Cardinal Health's (CAH) latest acquisition is expected to significantly improve patients' health outcomes with improved medication adherence and increased satisfaction.

Merit Medical's (MMSI) New Launch to Improve Patient Outcome

by Zacks Equity Research

Merit Medical's (MMSI) latest launch will likely aid in precisely targeting affected tissues, thereby resulting in more successful surgeries and improved patient outcomes.

Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Quest Diagnostics (DGX), CDC Sign New COVID-19 Testing Deal

by Zacks Equity Research

Quest Diagnostics (DGX) and the CDC tie up to provide COVID testing for underserved communities free of cost across the United States.

3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Cardinal Health (CAH) Buys Bendcare CPO-GPO, Invests in Its MSO

by Zacks Equity Research

Cardinal Health's (CAH) latest acquisition is expected to significantly boost its distribution opportunities and improve patient service.

LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity

by Zacks Equity Research

Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.

3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio

by Zacks Equity Research

Investors remain optimistic about Baxter (BAX) due to its strong product portfolio.

Study Favors Masimo's (MASI) SafetyNet for Better Patient Outcome

by Zacks Equity Research

Masimo's (MASI) SafetyNet is expected to reduce the duration of hospitalization for COVID-19 patients and create more bed capacity in hospitals.

3 Reasons to Add QuidelOrtho (QDEL) Stock to Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Here's Why You Should Buy ShockWave Medical (SWAV) Stock

by Zacks Equity Research

ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.

3 Reasons to Retain Veeva Systems (VEEV) Stock in Your Portfolio

by Zacks Equity Research

Veeva Systems' (VEEV) slew of strategic deals raises optimism about the stock.

Reasons to Add Patterson Companies (PDCO) to Your Portfolio

by Zacks Equity Research

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Has Merck & Co. (MRK) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Merck (MRK) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.

Company News for Jun 30, 2022

by Zacks Equity Research

Companies in The News Are: GIS,MKC,BBBY,PDCO

Patterson Companies (PDCO) Q4 Earnings Beat, Revenues Up Y/Y

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal fourth-quarter 2022 results benefit from strength in the Dental and Animal Health segments.

Patterson Cos. (PDCO) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 26.79% and 1.71%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Can Patterson Cos. (PDCO) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from its strength in the Animal Health business and robust product portfolio. However, stiff competition remains a woe.